A team of researchers at Tel Aviv University has developed a breakthrough RNA-based drug delivery system to target diseased cells that could improve the treatment of blood cancers, various types of solid cancers, different inflammatory diseases and viral diseases – including coronavirus.
“We are the first in the world to deliver the drug exclusively to cells that are currently relevant to the disease.”
Comments are closed.